Condition

ASCVD clinical trials and research

• 8Clinical trials
• 4Countries

Newest ASCVD clinical trials

All recruiting trials (8)

• ABP-745 to reduce atherosclerotic plaque in people with ASCVD

  This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.

  Recruiting Phase 2 Atom Therapeutics Co., Ltd · Beverly Hills, California and 32 other locations · NCT07303777

• Long-term remote ischemic conditioning to protect the heart, brain, and kidneys in very-high-risk ASCVD

  We will try regular remote ischemic conditioning to see if it protects the heart, brain, and kidneys in adults over 40 with very-high-risk ASCVD.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07270887

• Comparing two cholesterol-lowering treatments for diabetes risk in heart disease patients

  This study is testing whether a combination of two cholesterol-lowering medications can help heart disease patients with prediabetes avoid developing diabetes better than a stronger single medication.

  Recruiting Phase 4 Korea University Anam Hospital · Seoul · NCT06767774

• Blocking IL-1β to reduce artery inflammation in people with coronary artery disease, including those with TET2 clonal hematopoiesis

  This trial will see if canakinumab, a drug that blocks IL‑1β, reduces artery inflammation in adults with prior heart attack or coronary stents, some of whom have TET2 clonal hematopoiesis.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT06691217

• Evaluating HST101 for lowering cholesterol in Chinese patients

  This study is testing if a new drug called HST101 can lower cholesterol levels in Chinese patients who have high cholesterol and are at risk for heart disease.

  Recruiting at 17 sites Phase 3 Hasten Biopharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 17 other locations · NCT06568471

• Improving cholesterol management after heart events through education

  This study is testing if teaching doctors and patients about cholesterol management can help prevent future heart problems in people who have been hospitalized for a heart issue.

  Recruiting Duke University · Minneapolis, Minnesota · NCT06471036

• Investigating heart disease in testicular cancer survivors

  This study is testing if testicular cancer survivors who had certain treatments are at higher risk for heart disease, using blood tests and imaging to find early signs of problems.

  Recruiting Indiana University · Indianapolis, Indiana · NCT05611307

• Preventing cardiovascular and kidney disease in patients with type 2 diabetes

  This study is testing which of two diabetes treatments can better prevent heart and kidney problems in people with type 2 diabetes who are at high risk for cardiovascular disease.

  Recruiting at 36 sites Phase 4 Brigham and Women's Hospital · Huntsville, Alabama and 35 other locations · NCT05390892

Related topics

Quick answers

How many ASCVD clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), China (3 trials), Australia (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 4: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →